ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $27,173,000 | +52.2% | 157,892 | +10.6% | 0.03% | +55.6% |
| Q2 2021 | $17,851,000 | -5.3% | 142,741 | +2.7% | 0.02% | -14.3% |
| Q1 2021 | $18,854,000 | +17.4% | 139,030 | +10.8% | 0.02% | +10.5% |
| Q4 2020 | $16,057,000 | +22.8% | 125,502 | +8.0% | 0.02% | +5.6% |
| Q3 2020 | $13,079,000 | +33.6% | 116,228 | +13.1% | 0.02% | +28.6% |
| Q2 2020 | $9,791,000 | +21.1% | 102,768 | +14.2% | 0.01% | 0.0% |
| Q1 2020 | $8,085,000 | +90.8% | 89,961 | +12.6% | 0.01% | +133.3% |
| Q4 2019 | $4,237,000 | +29.8% | 79,908 | -3.3% | 0.01% | +20.0% |
| Q3 2019 | $3,264,000 | -5.2% | 82,608 | -1.4% | 0.01% | 0.0% |
| Q2 2019 | $3,443,000 | -27.9% | 83,808 | -18.3% | 0.01% | -28.6% |
| Q1 2019 | $4,778,000 | -7.7% | 102,602 | -13.7% | 0.01% | -22.2% |
| Q4 2018 | $5,179,000 | -16.2% | 118,921 | +10.1% | 0.01% | 0.0% |
| Q3 2018 | $6,182,000 | +43.6% | 108,021 | +21.8% | 0.01% | +28.6% |
| Q2 2018 | $4,304,000 | +51.4% | 88,700 | +22.0% | 0.01% | +75.0% |
| Q1 2018 | $2,843,000 | +8.9% | 72,700 | +18.2% | 0.00% | 0.0% |
| Q4 2017 | $2,610,000 | +13.7% | 61,500 | 0.0% | 0.00% | +33.3% |
| Q3 2017 | $2,295,000 | -4.2% | 61,500 | -22.0% | 0.00% | -25.0% |
| Q2 2017 | $2,395,000 | +15.7% | 78,800 | +0.8% | 0.00% | +33.3% |
| Q1 2017 | $2,070,000 | +11.1% | 78,200 | +7.1% | 0.00% | 0.0% |
| Q4 2016 | $1,863,000 | -20.8% | 73,000 | +12.3% | 0.00% | -25.0% |
| Q3 2016 | $2,352,000 | +11.6% | 65,000 | +4.8% | 0.00% | 0.0% |
| Q2 2016 | $2,107,000 | +30.7% | 62,000 | +1.5% | 0.00% | +33.3% |
| Q1 2016 | $1,612,000 | -47.6% | 61,100 | -3.2% | 0.00% | -50.0% |
| Q4 2015 | $3,077,000 | +97.4% | 63,100 | +0.8% | 0.01% | +100.0% |
| Q3 2015 | $1,559,000 | -20.4% | 62,600 | +1.1% | 0.00% | 0.0% |
| Q2 2015 | $1,959,000 | -18.8% | 61,900 | -2.4% | 0.00% | -25.0% |
| Q1 2015 | $2,413,000 | +8.8% | 63,400 | +11.4% | 0.00% | 0.0% |
| Q4 2014 | $2,217,000 | +32.4% | 56,900 | +2.7% | 0.00% | +33.3% |
| Q3 2014 | $1,675,000 | -11.7% | 55,400 | -0.7% | 0.00% | 0.0% |
| Q2 2014 | $1,896,000 | +76.2% | 55,800 | +78.8% | 0.00% | +50.0% |
| Q1 2014 | $1,076,000 | +144.5% | 31,200 | +181.1% | 0.00% | +100.0% |
| Q4 2013 | $440,000 | – | 11,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 1,480,060 | $53,563,000 | 85.86% |
| NEXTHERA CAPITAL LP | 217,817 | $7,883,000 | 4.84% |
| Novo Holdings A/S | 903,833 | $32,710,000 | 2.90% |
| SECTORAL ASSET MANAGEMENT INC | 481,765 | $17,435,000 | 1.71% |
| Perceptive Advisors | 589,890 | $21,348,000 | 1.38% |
| RA Capital Management | 318,565 | $11,529,000 | 1.19% |
| OAK RIDGE INVESTMENTS LLC | 1,226,468 | $44,386,000 | 1.15% |
| Granahan Investment Management | 817,149 | $29,573,000 | 0.97% |
| Eventide Asset Management | 428,900 | $15,522,000 | 0.95% |
| QVT Financial LP | 636,764 | $23,044,000 | 0.87% |